US4576173A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Electro-optical device and method for monitoring instanteous singlet oxygen concentration produced during photoradiation using a CW excitation source
Assignee: Johns Hopkins University
•
Filing: 1984-07-11
•
Granted: 1986-03-18
•
Expires: 2004-07-11
Abstract
Abstract A method and apparatus is disclosed for optically monitoring the concentration of singlet oxygen produced during photoradiation. A composite optical emission in the 1.27 micron frequency band is detected and electrically processed to separate a first component due to the decay of singlet oxygen from a second unwanted component due to the fluorescence of the photosensitizing dye. A chopped CW excitation source is used to excite the photosensitizing dye and a signal processing means such as a lock-in amplifier is used to separate the singlet oxygen emission component which appears out of phase from the chopped excitation signal and the in-phase photosensitizer fluorescence. The magnitude and/or other characteristics of the singlet oxygen emission component can be used to determine properties of complex biological or other media. In a therapeutic environment the magnitude and/or other characteristics of the singlet oxygen emission can be used by the treating physician to set a therapeutic light dosimetry.
Inventors
- 👤 John G. Parker
- 👤 William D. Stanbro
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:52
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6408; A; A61; A61B; A61B5/00; A61B5/0059; A61B90/00; A61B90/06; A61F; A61F9/00; A61F9/007; A61F9/008; A61F9/00821; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; G01N21/6428; A61B17/00; A61B2017/00017; A61B2017/00022; A61B2017/00057; A61B18/00; A61B18/18; A61B18/20; A61B2018/2035; A61B2018/2045; A61F2009/00897; A61F9/009; A61N2005/0635; A61N2005/0643; A61N2005/0644; G01N2021/6432
Claims Analysis
Total Claims: 44
Claim 1
Independent Claim
165 words
An apparatus for detecting singlet oxygen emission produced during photoradiation: an optical excitation means for illuminating a particular portion of a medium containing a photodynamic sensitizer with chopped optical radiation of a wavelength capable of at least causing generation of a singlet oxygen emission; an optical detection means for collecting light emitted from said medium and for detecting a composite optical signal in a 1.27 micron singlet oxygen emission band, the band having a bandwidth including a sensitizer fluorescent emission signal component and a singlet oxygen emission signal component that is out of phase with the fluorescent signal component; a signal processing means, operably associated with said optical detection means, for processing said composite optical signal and for separating said singlet oxygen signal component from said sensitizer fluorescent signal component by utilizing a difference in phase between the two signal components; and, a responsive means, operably associated with said signal processing means, for providing an indication of the magnitude of said singlet oxygen signal component.
Claim 2
Independent Claim
165 words
An apparatus for detecting singlet oxygen emission produced during photoradiation: an optical excitation means for illuminating a particular portion of a medium containing a photodynamic sensitizer with chopped optical radiation of a wavelength capable of at least causing generation of a singlet oxygen emission; an optical detection means for collecting light emitted from said medium and for detecting a composite optical signal in a 1.27 micron singlet oxygen emission band, the band having a bandwidth including a sensitizer fluorescent emission signal component and a singlet oxygen emission signal component that is out of phase with the fluorescent signal component; a signal processing means, operably associated with said optical detection means, for processing said composite optical signal and for separating said singlet oxygen signal component from said sensitizer fluorescent signal component by utilizing a difference in phase between the two signal components; and, a responsive means, operably associated with said signal processing means, for providing an indication of the magnitude of said singlet oxygen signal component.
Claim 3
Dependent Claim
46 words
The apparatus of claim 1, wherein said signal processing means includes means for determining the fundamental fourier component of said composite signal, and for outputting to said responsive means the magnitude of the component of said fundamental component that is out-of-phase from said chopped optical radiation.
Claim 4
Dependent Claim
29 words
The apparatus of claim 2, wherein said signal processing means includes means for separating a singlet oxygen component that is about 90° out of phase from said chopped radiation.
Claim 5
Dependent Claim
28 words
The apparatus of claim 1, wherein said signal processing means comprises a lock-in amplifier, and means for triggering the lock-in amplifier in sequence with said chopped optical radiation.
Claim 6
Dependent Claim
58 words
The apparatus of claim 4, further including: a chopping frequency scanning means for scanning the chopping frequency of said chopper across a plurality of frequencies, and for causing the chopper to chop at a chopping frequency corresponding to the maximum singlet oxygen component signal processed by said signal processing means for each of said plurality of chopping frequencies.
Claim 7
Dependent Claim
28 words
The apparatus of claim 5, wherein said chopping frequency scanning means includes means for scanning periodically the plurality of chopping frequencies to periodically select a desired chopping frequency.
Claim 8
Dependent Claim
14 words
The apparatus of claim 1, wherein said signal processing means comprises a lock-in amplifier.
Claim 9
Dependent Claim
32 words
The apparatus of claim 7, wherein said lock-in amplifier includes means for outputting the magnitude of the component of said fundamental component that is about 90° out-of-phase with said chopped optical radiation.
Claim 10
Dependent Claim
49 words
The apparatus of claim 1, wherein said optical excitation means includes a chopper that has a variable frequency control that may be set to chop at a frequency f c =1/(2πΥ D ), where Υ D equals the quenching time of singlet oxygen in a medium selected for photoradiation.
Claim 11
Dependent Claim
52 words
The apparatus of claim 1, wherein said optical excitation means includes: a light source means for producing optical radiation; a chopper, optically coupled to said light source for chopping said optical radiation; and, a light delivery means, optically coupled to said chopper, for directing a chopped optical radiation onto said biological medium.
Claim 12
Dependent Claim
46 words
The apparatus of claim 10, wherein said chopper has a variable frequency control that may be set to control the chopper at a chopping frequency f c =1/2πΥ D , where Υ D equals the quenching time of singlet oxygen in a medium selected for photoradiation.
Claim 13
Dependent Claim
17 words
The apparatus of claim 11, wherein said chopping frequency for a water medium is approximately 50 kHz.
Claim 14
Dependent Claim
21 words
The apparatus of claim 11 wherein said chopping frequency for a lipid medium is in the range 5 to 10 kHz.
Claim 15
Dependent Claim
27 words
The apparatus of claim 10, wherein said chopper includes means for controlling the chopper frequency and for maximizing the singlet oxygen component indicated by said responsive means.
Claim 16
Dependent Claim
65 words
The apparatus of claim 10, wherein said chopper includes a chopping frequency adjusting means for adjusting the chopping frequency of said chopper, said adjusting means including means for scanning said chopping frequency across a plurality of frequencies, and means for selecting a chopping frequency corresponding to the maximum singlet oxygen component signal magnitude processed by said signal processing means from said plurality of chopping frequencies.
Claim 17
Dependent Claim
62 words
The apparatus of claim 1, wherein said optical detection means includes: a light collecting means for collecting light emitted from biological media; a filter means for blocking light outside of the singlet oxygen 1.27 micron emission band; and, a photodetector means for converting the composite sensitizer fluorescence/singlet oxygen emission signal appearing in the 1.27 micron singlet oxygen band into an electrical signal.
Claim 18
Dependent Claim
27 words
The apparatus of claim 16, wherein said filter means is a bandpass filter centered at 1.27 microns having 3 dB downpoints at 1.26 microns and 1.28 microns.
Claim 19
Dependent Claim
30 words
The apparatus of claim 16, wherein said photodetector means has a decay response which falls off by 1/e in 0. 2 microseconds and to less than 1% in 1 microsecond.
Claim 20
Dependent Claim
18 words
The apparatus of claim 18, wherein said photodetector means is an Indium Gallium Arsenide/Indium Phosphide (InGaAs/InP) back/illuminated diode.
Claim 21
Dependent Claim
14 words
The apparatus of claim 16, wherein said light collecting means is a lens arrangement.
Claim 22
Dependent Claim
22 words
The apparatus of claim 16, wherein said light collecting means is a fiberoptic light guide adapted for insertion into said biological medium.
Claim 23
Dependent Claim
29 words
The apparatus of claim 16, wherein said light collecting means is a fiberoptic link optically coupled to a contact lens to be worn on a patient's eye during treatment.
Claim 24
Dependent Claim
128 words
A therapeutic light dosimetry procedure for use in the photoradiation therapeutic treatment of a living body, wherein said living body is injected with a photosensitive dye capable of generating singlet oxygen in said living body, said dosimetry procedure comprising the steps of: irradiating the injected photosensitizing dye with a certain light dosage, causing said photosensitizing dye to energize available local oxygen existing in said living body to generate singlet oxygen; detecting the emission produced from singlet oxygen radiative decay in the 1.27 micron singlet oxygen emission band from a plurality of different emissions in the same band that are caused by the light in the step of irradiating; determining the magnitude of the detected emissions to indicate the extent available local oxygen depletion has reduced singlet oxygen production.
Claim 25
Dependent Claim
128 words
A therapeutic light dosimetry procedure for use in the photoradiation therapeutic treatment of a living body, wherein said living body is injected with a photosensitive dye capable of generating singlet oxygen in said living body, said dosimetry procedure comprising the steps of: irradiating the injected photosensitizing dye with a certain light dosage, causing said photosensitizing dye to energize available local oxygen existing in said living body to generate singlet oxygen; detecting the emission produced from singlet oxygen radiative decay in the 1.27 micron singlet oxygen emission band from a plurality of different emissions in the same band that are caused by the light in the step of irradiating; determining the magnitude of the detected emissions to indicate the extent available local oxygen depletion has reduced singlet oxygen production.
Claim 26
Dependent Claim
120 words
A therapeutic light dosimetry procedure for use in the photoradiation therapeutic treatment of a living body, wherein said living body is injected with a photosensitizing dye capable of generating singlet oxygen in said living body, said dosimetry procedure comprising the steps of: generating singlet oxygen by photoradiating the injected photosensitizing dye with light; detecting the emission produced from singlet oxygen decay in the singlet oxygen 1.27 micron emission band from a plurality of different emissions in the same band that are caused by the photoradiation in the step of generating; determining the magnitude of the detected singlet oxygen emission; and, indicating the magnitude of detected singlet oxygen emission generated for the particular light dosage used in the step of generating.
Claim 27
Dependent Claim
120 words
A therapeutic light dosimetry procedure for use in the photoradiation therapeutic treatment of a living body, wherein said living body is injected with a photosensitizing dye capable of generating singlet oxygen in said living body, said dosimetry procedure comprising the steps of: generating singlet oxygen by photoradiating the injected photosensitizing dye with light; detecting the emission produced from singlet oxygen decay in the singlet oxygen 1.27 micron emission band from a plurality of different emissions in the same band that are caused by the photoradiation in the step of generating; determining the magnitude of the detected singlet oxygen emission; and, indicating the magnitude of detected singlet oxygen emission generated for the particular light dosage used in the step of generating.
Claim 28
Dependent Claim
87 words
A photoradiation procedure comprising: injecting a photosensitizing dye capable of generating singlet oxygen into a living body; generating singlet oxygen by photoradiating the injected photosensitizing dye; detecting the emission produced from singlet oxygen radiative decay in the singlet oxygen 1.27 micron emission band from a plurality of different emissions in the same band that are caused by the photoradiation in the step of generating; determining the magnitude of the detected singlet oxygen emission; and, adjusting the photoradiation in accordance with the magnitude of said singlet oxygen emission.
Claim 29
Dependent Claim
87 words
A photoradiation procedure comprising: injecting a photosensitizing dye capable of generating singlet oxygen into a living body; generating singlet oxygen by photoradiating the injected photosensitizing dye; detecting the emission produced from singlet oxygen radiative decay in the singlet oxygen 1.27 micron emission band from a plurality of different emissions in the same band that are caused by the photoradiation in the step of generating; determining the magnitude of the detected singlet oxygen emission; and, adjusting the photoradiation in accordance with the magnitude of said singlet oxygen emission.
Claim 30
Dependent Claim
120 words
A photoradiation procedure comprising: injecting a photosensitizing dye capable of generating singlet oxygen into a living body; irradiating the injected photosensitizing dye with optical energy, causing said photosensitizing dye to energize available local oxygen existing in said living body to generate singlet oxygen; detecting the emission produced from singlet oxygen radiative decay in the 1.27 micron singlet oxygen emission band from a plurality of different emissions in the same band that are caused by the optical energy in the step of irradiating; determining the magnitude of the detected singlet oxygen emission; and, adjusting the optical energy in accordance with the magnitude of said detected emission, to compensate for reduction in said available local oxygen which causes reduced singlet oxygen concentration.
Claim 31
Dependent Claim
120 words
A photoradiation procedure comprising: injecting a photosensitizing dye capable of generating singlet oxygen into a living body; irradiating the injected photosensitizing dye with optical energy, causing said photosensitizing dye to energize available local oxygen existing in said living body to generate singlet oxygen; detecting the emission produced from singlet oxygen radiative decay in the 1.27 micron singlet oxygen emission band from a plurality of different emissions in the same band that are caused by the optical energy in the step of irradiating; determining the magnitude of the detected singlet oxygen emission; and, adjusting the optical energy in accordance with the magnitude of said detected emission, to compensate for reduction in said available local oxygen which causes reduced singlet oxygen concentration.
Claim 32
Independent Claim
110 words
A method for directly monitoring the singlet oxygen level produced during photoradiation therapy, said method comprising the steps of: illuminating a portion of a biological medium containing a photodynamic sensitizer with chopped optical radiation having a wavelength which will cause the sensitizer to fluoresce and cause singlet oxygen decay emissions out of phase with the fluorescence; collecting light emitted from said biological medium; generating a composite sensitizer fluorescence/singlet oxygen emission signal from the collected light; processing said composite sensitizer fluorescence/singlet oxygen emission signal and separating the singlet oxygen component from the sensitizer fluorescent component based on their relative phase difference; and, indicating the magnitude of said singlet oxygen signal component.
Claim 33
Independent Claim
110 words
A method for directly monitoring the singlet oxygen level produced during photoradiation therapy, said method comprising the steps of: illuminating a portion of a biological medium containing a photodynamic sensitizer with chopped optical radiation having a wavelength which will cause the sensitizer to fluoresce and cause singlet oxygen decay emissions out of phase with the fluorescence; collecting light emitted from said biological medium; generating a composite sensitizer fluorescence/singlet oxygen emission signal from the collected light; processing said composite sensitizer fluorescence/singlet oxygen emission signal and separating the singlet oxygen component from the sensitizer fluorescent component based on their relative phase difference; and, indicating the magnitude of said singlet oxygen signal component.
Claim 34
Dependent Claim
44 words
The method of claim 27, wherein said processing step includes the steps of determining the fundamental fourier component of said sensitizer fluorescence/singlet oxygen emission signal and determining the magnitude of the component of said fundamental component that is out-of-phase with said chopped optical radiation.
Claim 35
Dependent Claim
28 words
The method of claim 28, wherein said separating step includes the step of separating the component that is about 90° out of phase with said chopped optical radiation.
Claim 36
Independent Claim
39 words
The method of claims 28 or 29, further including the steps of: scanning the chopping frequency of said optical radiation across a plurality of frequency values; and, selecting the chopping frequency which provides the largest singlet oxygen signal component.
Claim 37
Dependent Claim
28 words
The method of claim 30, further including the step of periodically scanning the chopping frequency and selecting the chopping frequency which produces the largest singlet oxygen signal component.
Claim 38
Dependent Claim
32 words
The method of claim 28 or 29, further including the step of: tuning the chopping frequency of said optical radiation to a particular value depending on the characteristics of the biological medium.
Claim 39
Dependent Claim
29 words
The method of claim 32, wherein said chopping frequency is set to approximately 50 kHz to detect singlet oxygen emission produced in an aqueous portion of the biological medium.
Claim 40
Dependent Claim
38 words
The method of claim 32, wherein said chopping frequency is tuned within a band of 5-10 Khz to detect the signal level attributable to the maximum signal oxygen emission produced in a lipid component of a biological medium.
Claim 41
Dependent Claim
24 words
The method of claim 27, further involving the step of chopping the optical excitation during periods when the singlet oxygen level is being measured.
Claim 42
Dependent Claim
25 words
The method of claim 27, further involving the step of adjusting the intensity of said optical radiation to increase or decrease the singlet oxygen level.
Claim 43
Dependent Claim
25 words
The method of claim 27, further involving the step of adjusting the frequency of said optical radiation to increase or decrease the singlet oxygen level.
Claim 44
Dependent Claim
25 words
The method of claim 27, further involving the step of adjusting the modulation of said optical radiation to increase or decrease the singlet oxygen level.
References Cited (Backward Citations)
US3136310A
Cited
US4336809A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-03-17 | 1989-09-16 | 1990-03-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-03-17 | 1993-09-16 | 1994-03-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-03-17 | 1997-09-16 | 1998-03-18 | $7700.00 | Window Closed / Lapsed |